Published in Hematology Week, October 9th, 2006
"Studies in mice and humans demonstrate that transplantation of hematopoietic progenitors in numbers larger than commonly used ('megadose' transplants) overcomes major genetic barriers.
"In vitro studies suggest that veto cells, within the population of hematopoietic progenitors, facilitate this favorable outcome. Tolerance induction can be further enhanced by other veto...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week